A novel combination therapy approach for the treatment of acute myeloid leukemia: the multi-kinase inhibitor sorafenib and the HDM2 inhibitor nutlin-3
about
A novel combination therapy approach for the treatment of acute myeloid leukemia: the multi-kinase inhibitor sorafenib and the HDM2 inhibitor nutlin-3
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
A novel combination therapy ap ...... nd the HDM2 inhibitor nutlin-3
@ast
A novel combination therapy ap ...... nd the HDM2 inhibitor nutlin-3
@en
type
label
A novel combination therapy ap ...... nd the HDM2 inhibitor nutlin-3
@ast
A novel combination therapy ap ...... nd the HDM2 inhibitor nutlin-3
@en
prefLabel
A novel combination therapy ap ...... nd the HDM2 inhibitor nutlin-3
@ast
A novel combination therapy ap ...... nd the HDM2 inhibitor nutlin-3
@en
P2860
P1433
P1476
A novel combination therapy ap ...... nd the HDM2 inhibitor nutlin-3
@en
P2093
Ellen Weisberg
Martin Sattler
P2860
P304
P356
10.3324/HAEMATOL.2012.078451
P577
2012-11-01T00:00:00Z